{"content":"<li class=\"n-box-item date-title\" data-end=\"1553659199\" data-start=\"1553572800\" data-txt=\"Monday, December 23, 2019\">Tuesday, March 26, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3445920\" data-ts=\"1553639168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABMD\" target=\"_blank\">ABMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445920-no-analyst-rates-abiomed-sell-shares-plunge-to-three-month-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No analyst rates Abiomed a Sell but shares plunge to three month low</a></h4><ul><li>Abiomed (NASDAQ:<a href='https://seekingalpha.com/symbol/ABMD' title='ABIOMED, Inc.'>ABMD</a>) plunged another 8.7% on heavy volume in today's trade to cap a 16% swoon over the past four sessions to its lowest price since December, sending the stock below both its 50- and 100-day moving averages.</li><li>ABMD does not have a single Sell or even a Hold rating from any of the 11 analysts who cover the medical device maker, according to Bloomberg data, and the average price target of $435 is or more than 50% above the stock's $286 closing price today.</li><li>Among the most confident analysts is Piper Jaffray's Matt O\u2019Brien, who is telling investors to \u201cstep up\u201d and add to positions in \u201cthe most open-ended growth story in med tech.\u201d</li><li>Piper blames the stock's weakness over the past six months on \u201cconfusion about the company\u2019s STEMI study,\u201d and ABMD said in a filing post-market Friday that William Bolt, senior VP of quality, regulatory and clinical operations, would <a href=\"https://www.sec.gov/Archives/edgar/data/815094/000156459019009012/abmd-8k_20190322.htm\" target=\"_blank\">leave the company next month</a> after 37 years.</li><li>Short interest in ABMD is running at ~2.5% of the shares freely available to trade, down from a recent peak above 2.65%, according to S3 Partners data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445920\" data-linked=\"No analyst rates Abiomed a Sell but shares plunge to three month low\" data-tweet=\"$ABMD - No analyst rates Abiomed a Sell but shares plunge to three month low https://seekingalpha.com/news/3445920-no-analyst-rates-abiomed-sell-shares-plunge-to-three-month-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3445920-no-analyst-rates-abiomed-sell-shares-plunge-to-three-month-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445919\" data-ts=\"1553638139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENZ\" target=\"_blank\">ENZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445919-enzo-biochemplus-23_5-holder-raises-stake-presses-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enzo Biochem +23.5% as holder raises stake, presses strategic review</a></h4><ul>   <li>Enzo Biochem (NYSE:<a href='https://seekingalpha.com/symbol/ENZ' title='Enzo Biochem, Inc.'>ENZ</a>) is <font color=\"green\">up 23.5%</font> after hours, in relatively light trading so far, after shareholder Roumell Asset Management <a href=\"https://seekingalpha.com/filing/4418388\" target=\"_blank\">notes in a filing</a> that it's boosted its stake to 4% and is seeking a review of strategic options.</li>    <li>Roumell had about 2.34% of the company as of the end of 2018.</li>    <li>In a letter to the board, Roumell says \"The stock price has declined by nearly 70% since the beginning of 2018. In fact, Enzo\u2019s stock trades below where it traded 20 years ago. We believe the time has come for the Board to recognize that the company is too small to be successful on its own.\"</li>    <li>\"We believe it\u2019s likely that the company\u2019s enviable product and IP portfolio would be better suited in a larger company\u2019s hands, where Enzo\u2019s promising AmpiProbe platform can go to market more efficiently and quickly,\" Roumell continues.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445919\" data-linked=\"Enzo Biochem +23.5% as holder raises stake, presses strategic review\" data-tweet=\"$ENZ - Enzo Biochem +23.5% as holder raises stake, presses strategic review https://seekingalpha.com/news/3445919-enzo-biochemplus-23_5-holder-raises-stake-presses-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3445919-enzo-biochemplus-23_5-holder-raises-stake-presses-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445917\" data-ts=\"1553637922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIL\" target=\"_blank\">GIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445917-gildan-activewarminus-3-after-warning-of-writeoff-from-distributors-liquidation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gildan Activewar -3% after warning of writeoff from distributor&#39;s liquidation</a></h4><ul><li>Gildan Activewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) <font color=\"red\">-3.4%</font> after-hours on news it expects to <a href=\"https://seekingalpha.com/pr/17456080-gildan-updates-guidance-reflect-anticipated-charge-related-heritage-distributor-wind\" target=\"_blank\">take a $19M-$23M charge</a> during Q1 related to the impairment of a trade receivable from Heritage Sportswear, a distributor that is expected to be liquidated.</li><li>GIL says the charge will reduce Q1 adjusted EPS guidance to the $0.14-$0.16 range after previously forecasting EPS of $0.24-$0.26; for the full year, GIL sees EPS of $1.90-$2.00  compared to previous guidance of $2.00-$2.10.</li><li>GIL says annual sales guidance remains unchanged, as the ~$60M/year business with Heritage will be mostly absorbed by other wholesale distributors within the channel.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445917\" data-linked=\"Gildan Activewar -3% after warning of writeoff from distributor&#39;s liquidation\" data-tweet=\"$GIL - Gildan Activewar -3% after warning of writeoff from distributor&#39;s liquidation https://seekingalpha.com/news/3445917-gildan-activewarminus-3-after-warning-of-writeoff-from-distributors-liquidation?source=tweet\" data-url=\"https://seekingalpha.com/news/3445917-gildan-activewarminus-3-after-warning-of-writeoff-from-distributors-liquidation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445915\" data-ts=\"1553637540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445915-xhrplus-5_2-crrminus-7_3-after-s-and-p-index-moves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XHR +5.2%; CRR -7.3% after S&amp;P index moves</a></h4><ul>   <li>Xenia Hotels &amp; Resorts (NYSE:<a href='https://seekingalpha.com/symbol/XHR' title='Xenia Hotels & Resorts, Inc.'>XHR</a>) is <font color=\"green\">up 5.2%</font> after hours as it's one of the companies making moves in the <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/898958_1dowspin100trex400.pdf?force_download=true\" target=\"_blank\">latest S&amp;P index changes</a>.</li>    <li>The company is moving into the SmallCap 600, where it will replace Trex (NYSE:<a href='https://seekingalpha.com/symbol/TREX' title='Trex Company, Inc.'>TREX</a>), which is moving up into the MidCap 400. Trex will be replacing Integrated Device Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a>), set to be acquired by Renesas Electronics. <a href='https://seekingalpha.com/symbol/TREX' title='Trex Company, Inc.'>TREX</a> is <font color=\"red\">down 1.7%</font> postmarket.</li>    <li>That move is effective before the open on Monday, April 1.</li>    <li>In bigger index moves, the spin-off of Dow (DOW) from DowDuPont will be added to the S&amp;P 500 before the open on Tuesday, April 2, and making room for it is Brighthouse Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/BHF' title='Brighthouse Financial, Inc.'>BHF</a>), moving down to the MidCap 400.</li>    <li>There it will replace Pitney Bowes (NYSE:<a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a>), which will drop down to the SmallCap 600 and boot out Carbo Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>). <a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a> is <font color=\"red\">up 1.7%</font> after hours; <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> has <font color=\"red\">slid 7.3%</font>.</li>    <li>Dow will also be added to the S&amp;P 100, replacing Halliburton there.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445915\" data-linked=\"XHR +5.2%; CRR -7.3% after S&amp;P index moves\" data-tweet=\"$XHR $TREX $IDTI - XHR +5.2%; CRR -7.3% after S&amp;P index moves https://seekingalpha.com/news/3445915-xhrplus-5_2-crrminus-7_3-after-s-and-p-index-moves?source=tweet\" data-url=\"https://seekingalpha.com/news/3445915-xhrplus-5_2-crrminus-7_3-after-s-and-p-index-moves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445911\" data-ts=\"1553636263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCC\" target=\"_blank\">HCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445911-warrior-met-coal-oks-new-70m-stock-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Warrior Met Coal OKs new $70M stock buyback</a></h4><ul><li>Warrior Met Coal (NYSE:<a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal, Inc.'>HCC</a>) <font color=\"green\">+3.6%</font> after-hours following news it has authorized <a href=\"https://seekingalpha.com/pr/17455985-warrior-met-coal-announces-new-stock-repurchase-program\" target=\"_blank\">$70M in additional repurchases</a> of common stock, after exhausting its previous $40M buyback program.</li><li>HCC says it also plans to accumulate cash and pay a special dividend of as much as $229.4M in the near future.</li><li>The company says it is now able to make the payments as a result of its restricted payment offer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445911\" data-linked=\"Warrior Met Coal OKs new $70M stock buyback\" data-tweet=\"$HCC - Warrior Met Coal OKs new $70M stock buyback https://seekingalpha.com/news/3445911-warrior-met-coal-oks-new-70m-stock-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3445911-warrior-met-coal-oks-new-70m-stock-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445910\" data-ts=\"1553635841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445910-enz-uucc-phas-and-trox-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ENZ, UUCC, PHAS and TROX among notable after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/ENZ' title='Enzo Biochem, Inc.'>ENZ</a> <font color=\"green\">+24.9%</font>. <a href='https://seekingalpha.com/symbol/UUCC' title='UCI International Holdings, Inc.'>OTC:UUCC</a> <font color=\"green\">+16.5%</font>. <a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color=\"green\">+14.6%</font>. <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color=\"green\">+6.5%</font>. <a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a> <font color=\"green\">+4.9%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a> <font color=\"red\">-6.5%</font>. <a href='https://seekingalpha.com/symbol/TROX' title='Tronox Limited'>TROX</a> <font color=\"red\">-4.2%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings, Inc.'>OLLI</a> <font color=\"red\">-3.1%</font>. <a href='https://seekingalpha.com/symbol/BJ' title='BJ&#39;s Wholesale Club Holdings, Inc.'>BJ</a> <font color=\"red\">-2.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445910\" data-linked=\"ENZ, UUCC, PHAS and TROX among notable after hours movers\" data-tweet=\"$ENZ $UUCC $SCVL - ENZ, UUCC, PHAS and TROX among notable after hours movers https://seekingalpha.com/news/3445910-enz-uucc-phas-and-trox-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445910-enz-uucc-phas-and-trox-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445909\" data-ts=\"1553635471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445909-aeterna-zentaris-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeterna Zentaris beats on revenue</a></h4><ul><li>Aeterna Zentaris (NASDAQ:<a href='https://seekingalpha.com/symbol/AEZS' title='Aeterna Zentaris Inc.'>AEZS</a>): Q4 GAAP EPS of -$0.31.</li><li>Revenue of $1.4M (+600.0% Y/Y) <font color=\"green\">beats by $1.15M</font>.</li><li>Shares <font color=\"green\">+1.69%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17456097-aeterna-zentaris-reports-fourth-quarter-full-year-2018-financial-operating-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445909\" data-linked=\"Aeterna Zentaris beats on revenue\" data-tweet=\"$AEZS - Aeterna Zentaris beats on revenue https://seekingalpha.com/news/3445909-aeterna-zentaris-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3445909-aeterna-zentaris-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445908\" data-ts=\"1553635446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCG\" target=\"_blank\">WCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445908-wellcare-healthplus-13-centene-holds-takeover-talks-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WellCare Health +13% as Centene holds takeover talks - Bloomberg</a></h4><ul><li>WellCare Health Plans (NYSE:<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a>) <font color=\"green\">+12.8%</font> after-hours following a CNBC report that Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) is <a href=\"https://www.bloomberg.com/news/articles/2019-03-26/centene-is-said-to-hold-takeover-discussions-with-wellcare\" target=\"_blank\">holding takeover talks</a> with the company.</li><li>A deal reportedly could come as soon as early April if negotiations are successful, although deal terms are not known.</li><li>Health insurer CNC has ~14M members and focuses on Medicaid and Affordable Care Act markets; WCG has a similar business focused on Medicaid, Medicare and ACA plans, with ~5.5M members.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445908\" data-linked=\"WellCare Health +13% as Centene holds takeover talks - Bloomberg\" data-tweet=\"$WCG $CNC - WellCare Health +13% as Centene holds takeover talks - Bloomberg https://seekingalpha.com/news/3445908-wellcare-healthplus-13-centene-holds-takeover-talks-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3445908-wellcare-healthplus-13-centene-holds-takeover-talks-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445893\" data-ts=\"1553633278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICCC\" target=\"_blank\">ICCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445893-immucell-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmuCell readies equity offering</a></h4><ul><li>ImmuCell (NASDAQ:<a href='https://seekingalpha.com/symbol/ICCC' title='ImmuCell Corporation'>ICCC</a>) <a href=\"https://seekingalpha.com/pr/17455986-immucell-corporation-announces-commencement-public-offering-common-stock\" target=\"_blank\">launches </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445893\" data-linked=\"ImmuCell readies equity offering\" data-tweet=\"$ICCC - ImmuCell readies equity offering https://seekingalpha.com/news/3445893-immucell-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3445893-immucell-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445891\" data-ts=\"1553633000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBL\" target=\"_blank\">CBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445891-cbl-to-suspend-dividends-payable-in-q3-and-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBL to suspend dividends payable in Q3 and Q4</a></h4><ul><li>CBL Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">falls 1.1%</font> in after-hours trading after announcing it<a href=\"https://seekingalpha.com/pr/17455996-cbl-properties-announces-proposed-settlement-class-action-lawsuit\" target=\"_blank\"> will suspend</a> payment of its common dividend for two quarters under a proposed class-action settlement that alleged the shopping center owner overcharged tenants at bulk metered malls for electricity.</li><li>CBL denies all allegations. It said it believes the the proposed settlement is in CBL's and its shareholders' best interests, considering a trial was set to start on April 2 and the potential cost of an adverse resolution of litigation.</li><li>Under the settlement, CBL<a href=\"https://seekingalpha.com/filing/4418555\" target=\"_blank\"> is required</a> to set aside a fund with monetary and non-monetary value of $90M to be disbursed to class members.</li><li>The suspension of the dividend will preserve ~$26M in cash at the current quarterly dividend rate.</li><li>CBL believes it will satisfy all required REIT distributions for the 2019 taxable year.</li><li>The company anticipates resuming a quarterly distributions with its dividend payable in January 2020 in an amount to be determined at the time.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431135-cbls-2019-ffo-guidance-trails-consensus-estimate\" target=\"_blank\">CBL's 2019 FFO guidance trails consensus estimate</a> (Feb. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445891\" data-linked=\"CBL to suspend dividends payable in Q3 and Q4\" data-tweet=\"$CBL - CBL to suspend dividends payable in Q3 and Q4 https://seekingalpha.com/news/3445891-cbl-to-suspend-dividends-payable-in-q3-and-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3445891-cbl-to-suspend-dividends-payable-in-q3-and-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>186&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445882\" data-ts=\"1553631861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445882-veonminus-1_9-announces-telenor-offering-85m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veon -1.9% as it announces Telenor offering 85M shares</a></h4><ul>   <li>Veon (NASDAQ:<a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd.'>VEON</a>) is <font color=\"red\">off 1.9%</font> postmarket after announcing that shareholder Telenor East Holding II (<a href='https://seekingalpha.com/symbol/TELNY' title='Telenor ASA'>OTCPK:TELNY</a>) is <a href=\"https://seekingalpha.com/pr/17455994-veon-ltd-announces-telenor-share-sale\" target=\"_blank\">offering up to 85M shares for sale</a>.</li>    <li>That makes up 4.9% of total Veon equity; Telenor's current Veon stake sits at 257M ADS, or 14.6% overall.</li>    <li>Veon won't receive any proceeds from the sale and it won't result in any dilution.</li>    <li>It's the latest in a series of Veon share sales by the Norwegian telecom, which offered up sales in September 2016, April 2017 and September 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445882\" data-linked=\"Veon -1.9% as it announces Telenor offering 85M shares\" data-tweet=\"$VEON $TELNY $TELNF - Veon -1.9% as it announces Telenor offering 85M shares https://seekingalpha.com/news/3445882-veonminus-1_9-announces-telenor-offering-85m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3445882-veonminus-1_9-announces-telenor-offering-85m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445876\" data-ts=\"1553631511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POLA\" target=\"_blank\">POLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445876-polar-power-misses-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Polar Power misses by $0.03, beats on revenue</a></h4><ul><li>Polar Power (NASDAQ:<a href='https://seekingalpha.com/symbol/POLA' title='Polar Power, Inc.'>POLA</a>): Q4 GAAP EPS of $0.00 <span style=\"color:red\">misses by $0.03</span>.</li><li>Revenue of $8.29M (+108.3% Y/Y) <font color=\"green\">beats by $0.29M</font>.</li><li>Shares <font color=\"green\">+1.54%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17456003-polar-power-reports-fourth-quarter-full-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445876\" data-linked=\"Polar Power misses by $0.03, beats on revenue\" data-tweet=\"$POLA - Polar Power misses by $0.03, beats on revenue https://seekingalpha.com/news/3445876-polar-power-misses-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3445876-polar-power-misses-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445873\" data-ts=\"1553631485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCVL\" target=\"_blank\">SCVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445873-shoe-carnivalplus-8-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shoe Carnival +8% after earnings topper</a></h4><ul><li>Shoe Carnival (NASDAQ:<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a>) pops after cruising past estimates with its <a href=\"https://seekingalpha.com/pr/17455959-shoe-carnival-reports-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Q4</a> report.</li><li>Comparable sales rose 4.7% during the quarter, driven by positive results for both the athletic and non-athletic footwear categories.</li><li>Gross margin fell 50 bps to 28.4% in Q4.</li><li>Net income was +$1.4M vs. -$3.9M a year ago.</li><li>SCVL <font color=\"green\">+8.27%</font> AH.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445864-shoe-carnival-beats-0_03-beats-revenue\" target=\"_blank\">Shoe Carnival beats by $0.03, beats on revenue</a> (March 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445873\" data-linked=\"Shoe Carnival +8% after earnings topper\" data-tweet=\"$SCVL - Shoe Carnival +8% after earnings topper https://seekingalpha.com/news/3445873-shoe-carnivalplus-8-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3445873-shoe-carnivalplus-8-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445864\" data-ts=\"1553630928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCVL\" target=\"_blank\">SCVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445864-shoe-carnival-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shoe Carnival beats by $0.03, beats on revenue</a></h4><ul><li>Shoe Carnival (NASDAQ:<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a>): Q4 GAAP EPS of $0.09 <span style=\"color:green\">beats by $0.03</span>.</li><li>Revenue of $234.66M (-3.5% Y/Y) <font color=\"green\">beats by $1.82M</font>.</li><li>Shares <font color=\"green\">+6.4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17455959-shoe-carnival-reports-fourth-quarter-fiscal-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445864\" data-linked=\"Shoe Carnival beats by $0.03, beats on revenue\" data-tweet=\"$SCVL - Shoe Carnival beats by $0.03, beats on revenue https://seekingalpha.com/news/3445864-shoe-carnival-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3445864-shoe-carnival-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445856\" data-ts=\"1553630236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445856-select-specialty-retailers-bid-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select specialty retailers bid up</a></h4><ul> <li>A number of specialty retailers are outperforming broad market averages on the day.</li> <li>Blue Apron (<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a> <font color='green'>+7.2%</font>), Farfetch (<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch'>FTCH</a> <font color='green'>+6.2%</font>), The Container Store (<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+5.2%</font>), Michaels Companies (<a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies, Inc.'>MIK</a> <font color='green'>+2.9%</font>) and RumbleOn (<a href='https://seekingalpha.com/symbol/RMBL' title='RumbleON, Inc.'>RMBL</a> <font color='green'>+7.2%</font>) are all notably higher.</li> <li>There is some chatter that traders are eying certain names in the sector following the activist action at Bed Bath &amp; Beyond.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445614-bed-bath-and-beyond-plus-16-percent-activists-gearing\" target=\"_blank\">Bed Bath &amp; Beyond +16% with activists gearing up</a> (March 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445856\" data-linked=\"Select specialty retailers bid up\" data-tweet=\"$APRN $FTCH $TCS - Select specialty retailers bid up https://seekingalpha.com/news/3445856-select-specialty-retailers-bid-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3445856-select-specialty-retailers-bid-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445854\" data-ts=\"1553629745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445854-dish-network-univision-settle-dispute-long-term-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network, Univision settle dispute with long-term deal</a></h4><ul>   <li>Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+2.8%</font>) and Univision (<a href='https://seekingalpha.com/symbol/UVN' title='Univision'>UVN</a>) have made peace and settled a longstanding channel carriage dispute via a <a href=\"https://seekingalpha.com/pr/17455920-dish-univision-reach-long-term-agreement-restore-channels-dish-dishlatino-customers\" target=\"_blank\">new long-term agreement</a>.</li>    <li>Restoration of Univision's channels to Dish and DishLATINO will begin immediately, they say.</li>    <li>That covers Univision, UniMas, Univision Deportes, Galavision, Tlnovelas and FOROtv.</li>    <li>The two companies also agreed to settle all pending litigation. Lawsuits had sprung up as part of the sticky dispute in the meantime.</li>    <li>Dish had dropped the channels at the end of June 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445854\" data-linked=\"Dish Network, Univision settle dispute with long-term deal\" data-tweet=\"$UVN $DISH - Dish Network, Univision settle dispute with long-term deal https://seekingalpha.com/news/3445854-dish-network-univision-settle-dispute-long-term-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3445854-dish-network-univision-settle-dispute-long-term-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445852\" data-ts=\"1553628986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445852-sprint-t-mobile-jump-delrahim-reportedly-open-to-merger-argument\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint, T-Mobile jump as Delrahim reportedly open to merger argument</a></h4><ul>   <li>Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+1.1%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+0.9%</font>) have spiked higher in the past few minutes after Fox's Charlie Gasparino says U.S. antitrust chief Makan Delrahim is <a href=\"https://twitter.com/CGasparino/status/1110623425486303233\" target=\"_blank\">\"open\" to an argument the two companies are advancing</a> for their $26B merger.</li>    <li>The two underdog carriers have been making the case that their deal should be approved in order to help the U.S. beat China to widespread mobile 5G adoption.</li>    <li>The deal must be approved at the FCC and Justice Dept. levels; Gasparino indicates that for the DOJ's part, Delrahim is receptive to that tack, while the FCC has <a href=\"https://seekingalpha.com/news/3441020-fcc-pauses-t-mobile-sprint-merger-review-new-information\" target=\"_blank\">paused its review of the merger</a> until April 4 in order to take in new public comment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445852\" data-linked=\"Sprint, T-Mobile jump as Delrahim reportedly open to merger argument\" data-tweet=\"$S $TMUS - Sprint, T-Mobile jump as Delrahim reportedly open to merger argument https://seekingalpha.com/news/3445852-sprint-t-mobile-jump-delrahim-reportedly-open-to-merger-argument?source=tweet\" data-url=\"https://seekingalpha.com/news/3445852-sprint-t-mobile-jump-delrahim-reportedly-open-to-merger-argument\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445761\" data-ts=\"1553628220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445761-health-insurers-managed-care-players-in-red-on-doj-brief-on-aca\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers/managed care players in the red on DOJ brief on ACA</a></h4><ul><li>Health insurers are under pressure in response to a <a href=\"https://theincidentaleconomist.com/wordpress/wp-content/uploads/2019/03/letter-from-DOJ.pdf\" target=\"_blank\">brief</a> from the U.S. Department of Justice siding with a December 2018 ruling by a Texas district court that the Affordable Care Act &#40;ACA&#41;, also known as Obamacare, is <a href=\"https://reason.com/volokh/2019/03/25/justice-department-revises-its-position\" target=\"_blank\">unconstitutional </a>and should be struck down.</li><li>Considering the Democratic majority in the House, however, a significant change to the ACA seems remote.</li><li>Selected tickers: Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"red\">-1.1%</font>), WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-2.5%</font>), UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-0.5%</font>), Triple-S Management (<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color=\"red\">-2.2%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"red\">-6.5%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-1.8%</font>), Civitas Solutions (<a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-1.2%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-2.7%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-1.6%</font>)</li><li><strong>Update</strong>: Hospital operators in the red: Universal Health Services (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services, Inc.'>UHS</a> <font color=\"red\">-0.5%</font>), Surgery Partners (<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color=\"red\">-2.9%</font>), Select Medical Holdings (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color=\"red\">-1.1%</font>), Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color=\"red\">-10.9%</font>), Nobilis Health (<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color=\"red\">-0.1%</font>), Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"red\">-2.7%</font>), Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color=\"red\">-2.3%</font>), HCA (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a> <font color=\"red\">-2.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445761\" data-linked=\"Health insurers/managed care players in the red on DOJ brief on ACA\" data-tweet=\"$HIIQ $WCG $UNH - Health insurers/managed care players in the red on DOJ brief on ACA https://seekingalpha.com/news/3445761-health-insurers-managed-care-players-in-red-on-doj-brief-on-aca?source=tweet\" data-url=\"https://seekingalpha.com/news/3445761-health-insurers-managed-care-players-in-red-on-doj-brief-on-aca\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445845\" data-ts=\"1553627652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445845-pe-firms-said-to-passed-on-bed-bath-beyond-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PE firms said to have passed on Bed Bath &amp; Beyond bid</a></h4><ul> <li>Shares of Bed Bath Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+20.5%</font>) are off their session high after CNBC <a href=\"https://www.cnbc.com/2019/03/26/bed-bath-beyond-has-been-a-puzzle-others-have-passed-on-solving.html\" target=\"_blank\">reports</a> \"multiple\" PE firms and at least one prominent activist investor have passed on making an offer for the retailer over the last few years.</li><li>Even with today's outsized gain, Bed Bath &amp; Beyond trades about 30% below its 52-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445845\" data-linked=\"PE firms said to have passed on Bed Bath &amp; Beyond bid\" data-tweet=\"$BBBY - PE firms said to have passed on Bed Bath &amp; Beyond bid https://seekingalpha.com/news/3445845-pe-firms-said-to-passed-on-bed-bath-beyond-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3445845-pe-firms-said-to-passed-on-bed-bath-beyond-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445843\" data-ts=\"1553627073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445843-evercore-calls-liveramp-pullback-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore calls LiveRamp pullback &quot;overdone&quot;</a></h4><ul><li>Evercore ISI analyst Kirk Materne says the LiveRamp (NYSE:<a href='https://seekingalpha.com/symbol/RAMP' title='LiveRamp Holdings, Inc.'>RAMP</a>) pullback in reaction to potential Google ad tool changes is \"overdone.\"</li><li>Materne writes that while changes could impact LiveRamp, offline data and cookies are \"just one piece of the puzzle as it relates to people based marketing.\"</li><li>He says the risk-reward balance remains favorable and thinks the pullback creates an attractive entry point for long-term investors.</li><li>Rating maintained at Outperform with a $70 target.</li><li>RAMP is <font color=\"red\">down 5.7%</font> to $55.48.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445411-ad-tech-firms-drop-google-mulls-chrome-ad-changes\" target=\"_blank\">Ad-tech firms drop as Google mulls Chrome ad changes</a> (March 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445843\" data-linked=\"Evercore calls LiveRamp pullback &quot;overdone&quot;\" data-tweet=\"$RAMP - Evercore calls LiveRamp pullback &quot;overdone&quot; https://seekingalpha.com/news/3445843-evercore-calls-liveramp-pullback-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3445843-evercore-calls-liveramp-pullback-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445841\" data-ts=\"1553626387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PE\" target=\"_blank\">PE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445841-parsley-energyplus-3-after-2019-production-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Parsley Energy +3% after 2019 production update</a></h4><ul><li>Parsley Energy (<a href='https://seekingalpha.com/symbol/PE' title='Parsley Energy, Inc.'>PE</a> <font color='green'>+2.9%</font>) pushes higher after reiterating FY 2019 production guidance while anticipating $1.35B-$1.55B of total development expenditures.</li><li>In a <a href=\"http://s21.q4cdn.com/387064974/files/doc_presentations/2019/03/PE_Presentation_2019_0325.pdf\" target=\"_blank\">new investor presentation</a>, PE forecasts an increase in FY 2019 net production to 80K-85K bbl/day of oil from 68.5K bbl/day during 2018, and Q1 net oil production of 75.5K-78K bbl/day.</li><li>PE also reports its drilling efficiency improved 13% Y/Y in 2018 and completion efficiency climbed 27% in the period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445841\" data-linked=\"Parsley Energy +3% after 2019 production update\" data-tweet=\"$PE - Parsley Energy +3% after 2019 production update https://seekingalpha.com/news/3445841-parsley-energyplus-3-after-2019-production-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3445841-parsley-energyplus-3-after-2019-production-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445840\" data-ts=\"1553626085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445840-dropcar-leads-tech-gainers-qutoutiao-and-the9-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DropCar leads tech gainers; Qutoutiao and The9 among losers</a></h4><ul><li><b>Gainers:</b> DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+30%</font>. Lantronix (NASDAQ:<a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a>) <font color=\"green\">+28%</font>. Spark Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/LOV' title='Spark Networks SE'>LOV</a>) <font color=\"green\">+19%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"green\">+17%</font>. Gridsum Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding Inc.'>GSUM</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers:</b> Helios and Matheson Analytics (<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics Inc.'>OTC:HMNY</a>) <font color=\"red\">-53%</font>. Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) <font color=\"red\">-18%</font>. Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <font color=\"red\">-14%</font>. The9 (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"red\">-10%</font>. Ability (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445840\" data-linked=\"DropCar leads tech gainers; Qutoutiao and The9 among losers\" data-tweet=\"$DCAR $LTRX $LOV - DropCar leads tech gainers; Qutoutiao and The9 among losers https://seekingalpha.com/news/3445840-dropcar-leads-tech-gainers-qutoutiao-and-the9-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445840-dropcar-leads-tech-gainers-qutoutiao-and-the9-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445834\" data-ts=\"1553624861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445834-noble-energy-shell-to-partner-for-colombia-offshore-blocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Energy, Shell to partner for Colombia offshore blocks</a></h4><ul><li>Noble Energy (<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color='green'>+2.4%</font>) <a href=\"https://www.upstreamonline.com/live/1739540/shell-partners-with-noble-energy-off-colombia\" target=\"_blank\">agrees to buy a 40% operating stake</a> in two offshore exploration and production contracts offshore Colombia to Royal Dutch Shell (<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='green'>+0.7%</font>) for an unspecified sum.</li><li>The contracts are for the Col-3 and Gua-3 blocks, which cover an area of 880K hectares (2,175 acres) in the Caribbean Sea.</li><li>The companies expect to invest $100M for the first phase of exploration in both blocks, Bloomberg reports.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445834\" data-linked=\"Noble Energy, Shell to partner for Colombia offshore blocks\" data-tweet=\"$NBL $RDS.A $RDS.B - Noble Energy, Shell to partner for Colombia offshore blocks https://seekingalpha.com/news/3445834-noble-energy-shell-to-partner-for-colombia-offshore-blocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3445834-noble-energy-shell-to-partner-for-colombia-offshore-blocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445812\" data-ts=\"1553623617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445812-u-s-trade-court-recommends-iphone-ban\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. trade court recommends iPhone ban</a></h4><ul><li><strong>Update</strong>: Apple shares give up earlier gains and are now in the red <font color=\"red\">0.07%</font>.</li><li><strong>Update:</strong> A <a href=\"https://www.bloomberg.com/news/articles/2019-03-26/apple-infringes-qualcomm-patent-judge-recommends-iphone-ban\" target=\"_blank\">trade judge</a> in one of two cases before the U.S. International Trade Commission found that one of the three patents under consideration was violated. The decision is subject to review by the full ITC commission.</li><li>An ITC decision on the other Apple-Qualcomm case is expected later today.</li><li>Qualcomm shares are<font color=\"green\"> up 1.7%</font> to $57.59.</li><li><strong>Original post:</strong> A U.S. trade court rules that Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) infringed on a Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) patent and recommends an import ban on some iPhone models.</li><li>Headlines only right now and post will update with more information.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445812\" data-linked=\"U.S. trade court recommends iPhone ban\" data-tweet=\"$QCOM $AAPL $AAPL - U.S. trade court recommends iPhone ban https://seekingalpha.com/news/3445812-u-s-trade-court-recommends-iphone-ban?source=tweet\" data-url=\"https://seekingalpha.com/news/3445812-u-s-trade-court-recommends-iphone-ban\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>135&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445807\" data-ts=\"1553623337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445807-key-energy-services-and-ferroglobe-among-energy-materials-gainers-ramco-resources-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key Energy Services and Ferroglobe among Energy/Materials gainers; Ramco Resources and SAExploration among losers</a></h4><ul><li><b>Gainers: </b>Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+13%</font>. Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"green\">+9%</font>. RPC (NYSE:<a href='https://seekingalpha.com/symbol/RES' title='RPC, Inc.'>RES</a>) <font color=\"green\">+6%</font>. Auryn Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/AUG' title='Auryn Resources Inc.'>AUG</a>) <font color=\"green\">+6%</font>. Companhia Siderurgica Nacional (NYSE:<a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderúrgica Nacional'>SID</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Ramaco Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/METC' title='Ramaco Resources, Inc.'>METC</a>) <font color=\"red\">-10%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-9%</font>.  Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-9%</font>. Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"red\">-7%</font>. Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445807\" data-linked=\"Key Energy Services and Ferroglobe among Energy/Materials gainers; Ramco Resources and SAExploration among losers\" data-tweet=\"$KEG $GSM $RES - Key Energy Services and Ferroglobe among Energy/Materials gainers; Ramco Resources and SAExploration among losers https://seekingalpha.com/news/3445807-key-energy-services-and-ferroglobe-among-energy-materials-gainers-ramco-resources-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3445807-key-energy-services-and-ferroglobe-among-energy-materials-gainers-ramco-resources-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445806\" data-ts=\"1553623273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445806-bed-bath-beyond-responds-to-activist-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond responds to activist group</a></h4><ul><li>Bed Bath &amp; Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+21.2%</font>) responds to the slate of 16 candidates nominated to the board by activist investors Legion Partners Asset Management, Macellum and Anoca Advisors.</li><li>The company says it regularly engages with shareholders and welcomes constructive input focused on enhancing value. Bed Bath &amp; Beyond also points to the comprehensive transformation it says is already in place to evolve the foundational structure of the business, drive shareholder value and best position it for long-term success.</li><li>In a release from the activist investor group, Bed Bath Beyond is described as having failed retail execution and strategy. The shareholder group believes BBBY has the potential to earn more than $5 in EPS annually over the next few years and is looking forward to sharing a detailed plan developed with its nominees over the coming weeks and months.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17455788-bed-bath-and-beyond-inc-issues-statement-regarding-activist-investor-group\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3445614-bed-bath-and-beyond-plus-16-percent-activists-gearing\" target=\"_blank\">Bed Bath &amp; Beyond +16% with activists gearing up</a> (March 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445806\" data-linked=\"Bed Bath &amp; Beyond responds to activist group\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond responds to activist group https://seekingalpha.com/news/3445806-bed-bath-beyond-responds-to-activist-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3445806-bed-bath-beyond-responds-to-activist-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445798\" data-ts=\"1553622203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDSO\" target=\"_blank\">MDSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445798-medidata-solutionsminus-3_6-on-cautious-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medidata Solutions -3.6% on cautious initiation</a></h4><ul><li>Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) <font color=\"red\">drops 3.6%</font> after <a href=\"https://www.streetinsider.com/Analyst+Comments/Medidata+Solutions+%28MDSO%29+Initiated+as+New+Short+at+Off+Wall+Street/15297857.html\" target=\"_blank\">an initiation</a> with a short recommendation at Off Wall Street citing multiple headwinds to long-term growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445798\" data-linked=\"Medidata Solutions -3.6% on cautious initiation\" data-tweet=\"$MDSO - Medidata Solutions -3.6% on cautious initiation https://seekingalpha.com/news/3445798-medidata-solutionsminus-3_6-on-cautious-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3445798-medidata-solutionsminus-3_6-on-cautious-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445796\" data-ts=\"1553621702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445796-nyse-suspends-trading-in-cloud-peak-energy-on-low-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYSE suspends trading in Cloud Peak Energy on low price</a></h4><ul>   <li>The NYSE has <a href=\"https://www.nyse.com/quote/XNYS:CLD\" target=\"_blank\">suspended trading</a> in Cloud Peak Energy (NYSE:<a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy Inc.'>CLD</a>), effective immediately.</li>    <li>That's due to \"abnormally low\" price levels.</li>    <li>The stock was trading at $0.16/share (<font color=\"red\">-5.2%</font> today), resulting in a market cap of just $12.07M.</li>    <li>The company issued a <a href=\"https://seekingalpha.com/news/3443267-cloud-peak-energy-minus-11-percent-issuing-going-concern-warning\" target=\"_blank\">going-concern warning</a> two weeks ago amid ongoing production problems and weaker demand.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445796\" data-linked=\"NYSE suspends trading in Cloud Peak Energy on low price\" data-tweet=\"$CLD $CLDPQ - NYSE suspends trading in Cloud Peak Energy on low price https://seekingalpha.com/news/3445796-nyse-suspends-trading-in-cloud-peak-energy-on-low-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3445796-nyse-suspends-trading-in-cloud-peak-energy-on-low-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445792\" data-ts=\"1553619737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445792-vertex-energy-and-mict-among-industrial-gainers-fuel-tech-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex Energy and MICT among industrial gainers; Fuel Tech leads the losers</a></h4><ul><li><b>Gainers: </b>Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>) <font color=\"green\">+8%</font>. MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"green\">+8%</font>. Select Interior Concepts (NASDAQ:<a href='https://seekingalpha.com/symbol/SIC' title='Select Interior Concepts, Inc.'>SIC</a>) <font color=\"green\">+6%</font>. Vertex Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/VTNR' title='Vertex Energy, Inc.'>VTNR</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"red\">-8%</font>. Air Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/AIRI' title='Air Industries Group'>AIRI</a>) <font color=\"red\">-8%</font>. Loma Negra Compania Industrial Argentina Sociedad (NYSE:<a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compañía Industrial Argentina Sociedad Anónima'>LOMA</a>) <font color=\"red\">-7%</font>. Beacon Roofing Supply (NASDAQ:<a href='https://seekingalpha.com/symbol/BECN' title='Beacon Roofing Supply, Inc.'>BECN</a>) <font color=\"red\">-5%</font>. Orion Group (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445792\" data-linked=\"Vertex Energy and MICT among industrial gainers; Fuel Tech leads the losers\" data-tweet=\"$INS $MICT $SIC - Vertex Energy and MICT among industrial gainers; Fuel Tech leads the losers https://seekingalpha.com/news/3445792-vertex-energy-and-mict-among-industrial-gainers-fuel-tech-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445792-vertex-energy-and-mict-among-industrial-gainers-fuel-tech-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445791\" data-ts=\"1553619594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445791-wheeler-real-estate-investment-trust-leads-financial-gainers-yirendai-and-grupo-financiero\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheeler Real Estate Investment Trust leads financial gainers; Yirendai and Grupo Financiero Galicia among losers</a></h4><ul><li><b>Gainers:</b> Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLRP' title='Wheeler Real Estate Investment Trust, Inc.'>WHLRP</a>) <font color=\"green\">+8%</font>. China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"green\">+6%</font>. Meta Financial Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CASH' title='Meta Financial Group, Inc.'>CASH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a>) <font color=\"red\">-7%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"red\">-7%</font>. Grupo Financiero Galicia (NASDAQ:<a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445791\" data-linked=\"Wheeler Real Estate Investment Trust leads financial gainers; Yirendai and Grupo Financiero Galicia among losers\" data-tweet=\"$WHLRP $XRF $CASH - Wheeler Real Estate Investment Trust leads financial gainers; Yirendai and Grupo Financiero Galicia among losers https://seekingalpha.com/news/3445791-wheeler-real-estate-investment-trust-leads-financial-gainers-yirendai-and-grupo-financiero?source=tweet\" data-url=\"https://seekingalpha.com/news/3445791-wheeler-real-estate-investment-trust-leads-financial-gainers-yirendai-and-grupo-financiero\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445790\" data-ts=\"1553619580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445790-nike-looks-to-cruise-past-ncaa-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike looks to cruise past NCAA probe</a></h4><ul> <li>Freshly indicted Michael Avenatti <a href=\"https://www.wsj.com/articles/michael-avenatti-claims-nike-paid-deandre-ayton-bol-bol-as-college-athletes-11553613868\" target=\"_blank\">alleges</a> that Nike (<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a> <font color='green'>+1.2%</font>) made payments to people close to Phoenix Suns player Deandre Ayton and University of Oregon player Bol Bol.</li> <li>Nike was subpoenaed last year as part of a broad government investigation into NCAA basketball. The company says it's cooperating with the probe.</li> <li>Shares of Nike are <font color=\"green\">up 1.14%</font> on the day and 12% YTD even after a bump last week after earnings.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445444-avenatti-arrested-extortion-scheme-nike\" target=\"_blank\">Avenatti arrested for extortion scheme against Nike</a> (March 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445790\" data-linked=\"Nike looks to cruise past NCAA probe\" data-tweet=\"$NKE - Nike looks to cruise past NCAA probe https://seekingalpha.com/news/3445790-nike-looks-to-cruise-past-ncaa-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3445790-nike-looks-to-cruise-past-ncaa-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445785\" data-ts=\"1553618844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445785-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers:</strong> Hunter Maritime Acquisition (NASDAQ:<a href='https://seekingalpha.com/symbol/HUNT' title='Hunter Maritime Acquisition Corp.'>HUNT</a>) <font color=\"green\">+154%</font>. Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"green\">+40%</font>. Castor Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRM' title='Castor Maritime Inc.'>CTRM</a>) <font color=\"green\">+31%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"green\">+25%</font>. Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+25%. </font>Lantronix (NASDAQ:<a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a>) <font color=\"green\">+22%</font>. DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+21%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"green\">+19%</font>. Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"green\">+16%</font>. Micron Solutions (NYSEMKT:<a href='https://seekingalpha.com/symbol/MICR' title='Micron Solutions, Inc.'>MICR</a>) <font color=\"green\">+12%</font>.</li><li><strong>Losers: </strong>Helios and Matheson Analytics (<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics Inc.'>OTC:HMNY</a>) <font color=\"red\">-52%</font>. Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"red\">-28%</font>. Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) <font color=\"red\">-17%</font>. Performance Shipping (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Performance Shipping Inc.'>DCIX</a>) <font color=\"red\">-12%</font>. Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) <font color=\"red\">-12%</font>. Neogen (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOG' title='Neogen Corporation'>NEOG</a>) <font color=\"red\">-11%</font>. NantKwest (NASDAQ:<a href='https://seekingalpha.com/symbol/NK' title='NantKwest, Inc.'>NK</a>) <font color=\"red\">-10%</font>. Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics, Inc.'>AXSM</a>) <font color=\"red\">-10%</font>. iClick Interactive Asia (NASDAQ:<a href='https://seekingalpha.com/symbol/ICLK' title='iClick Interactive Asia Group Limited'>ICLK</a>) <font color=\"red\">-10%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445785\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$HUNT $ALDX $CTRM - Midday Gainers / Losers https://seekingalpha.com/news/3445785-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445785-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445781\" data-ts=\"1553618364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445781-purdue-pharma-settles-opioid-case-in-ok-for-270m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Purdue Pharma settles opioid case in OK for $270M</a></h4><ul><li>Privately held Purdue Pharma LP has <a href=\"https://www.wsj.com/articles/purdue-reaches-270-million-settlement-with-oklahoma-in-opioid-crisis-case-11553606534?mod=hp_lead_pos4\" target=\"_blank\">agreed to pay</a> the state of Oklahoma $270M to settle litigation from the AG's office over its role in the opioid crisis there.</li><li>Oklahoma is one of 37 U.S. states suing the Oxycontin maker over its alleged aggressive marketing of the highly addictive pain killer. The company is also facing more than 1,600 lawsuits related to its promotion of opioids.</li><li>University of Georgia law professor Elizabeth Burch says, \u201cIt\u2019s got to set off a feeding frenzy since there's blood in the water now.\"</li><li>A bankruptcy filing by the company appears to be a near-certainty considering the size of the Oklahoma payment which sets a benchmark for future settlements.</li><li>Related tickers: Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"green\">+0.6%</font>), INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='INSYS Therapeutics, Inc.'>INSY</a> <font color=\"green\">+3.3%</font>), Titan Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color=\"green\">+1.7%</font>), Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"green\">+1.3%</font>), Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"green\">+0.7%</font>), Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a> <font color=\"green\">+0.9%</font>), AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+2%</font>), Opiant Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color=\"red\">-0.6%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+2.2%</font>), Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-0.8%</font>), Alkermes plc (<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color=\"green\">+2.1%</font>), Amphastar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar Pharmaceuticals, Inc.'>AMPH</a> <font color=\"green\">+0.5%</font>), Pain Therapeutics (<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics, Inc.'>PTIE</a> <font color=\"green\">+3.5%</font>), BioDelivery Sciences (<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color=\"green\">+1.8%</font>), Assertio Therapeutics (<a href='https://seekingalpha.com/symbol/ASRT' title='Assertio Therapeutics, Inc.'>ASRT</a> <font color=\"red\">-3.7%</font>), Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-0.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445781\" data-linked=\"Purdue Pharma settles opioid case in OK for $270M\" data-tweet=\"$ENDP $INSY $TTNP - Purdue Pharma settles opioid case in OK for $270M https://seekingalpha.com/news/3445781-purdue-pharma-settles-opioid-case-in-ok-for-270m?source=tweet\" data-url=\"https://seekingalpha.com/news/3445781-purdue-pharma-settles-opioid-case-in-ok-for-270m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445775\" data-ts=\"1553617277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445775-trump-reaches-across-aisle-on-drug-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump reaches across the aisle on drug prices</a></h4><ul><li>President Trump wants to <a href=\"https://www.reuters.com/article/us-usa-trump-drugs/trump-wants-to-work-with-democrats-on-drug-prices-infrastructure-aide-idUSKCN1R71VW\" target=\"_blank\">work with Democrats</a> on reducing U.S. drug prices, one of two areas (infrastructure funding) that his administration is seeking cooperation on. He has stated on numerous occasions that reining in drug prices is a top priority.</li><li>Drug makers appear to be moving quickly to raise prices before any government action. According to Reuters, about 30 companies have taken steps to end their self-declared moratorium on increases this year.</li><li>Executives from five pharmacy benefit managers will appear before the Senate Finance Committee on April 3 to answer questions about their roles in drug prices. Pharmaceutical executives <a href=\"https://seekingalpha.com/news/3437192-pharma-chiefs-defend-merits-current-system-innovation-senate-hearing\" target=\"_blank\">appeared </a>before the committee a month ago.</li><li>Selected tickers: UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-0.8%</font>), CVS Health (<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color=\"green\">+1.7%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-1.5%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-1.8%</font>), Takeda (<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a> <font color=\"green\">+1.7%</font>), Bausch Health Companies (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"green\">+1.2%</font>), Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"green\">+1.3%</font>), AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+1.9%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+2.3%</font>), AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"green\">+1.1%</font>), Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+1.8%</font>), GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"green\">+1.2%</font>), Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+1.6%</font>), Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"green\">+1.5%</font>), Merck (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"green\">+0.7%</font>), Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"green\">+1.1%</font>), Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+1.5%</font>), Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-0.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445775\" data-linked=\"Trump reaches across the aisle on drug prices\" data-tweet=\"$UNH $CVS $CI - Trump reaches across the aisle on drug prices https://seekingalpha.com/news/3445775-trump-reaches-across-aisle-on-drug-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3445775-trump-reaches-across-aisle-on-drug-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>264&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445771\" data-ts=\"1553616401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITB\" target=\"_blank\">ITB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445771-homebuilders-slide-after-housing-starts-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders slide after housing starts disappoint</a></h4><ul><li>Homebuilders stocks slip after February housing starts fell more than expected and consumer confidence slipped in March.</li><li>Meanwhile, the S&amp;P Corelogic Case-Shiller home price index rose less than expected in January, while the FHFA housing price index for the same month exceeded consensus.</li><li>BlackRock's iShares Dow Jones U.S. Home Construction ETF (NYSE:<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>) <font color=\"red\">falls 0.8%</font> in midday trading.</li><li>Hovnanian (<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a> <font color='red'>-2.2%</font>), usually pretty volatile, declines the most, followed by D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D.R. Horton, Inc.'>DHI</a> <font color='red'>-2%</font>), Taylor Morrison Homes (<a href='https://seekingalpha.com/symbol/TMHC' title='Taylor Morrison Home Corporation'>TMHC</a> <font color='red'>-1.1%</font>), NVR (<a href='https://seekingalpha.com/symbol/NVR' title='NVR, Inc.'>NVR</a> <font color='red'>-1.2%</font>), and Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers, Inc.'>TOL</a> <font color='red'>-0.9%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a>, <a href='https://seekingalpha.com/symbol/HOMZ' title='Hoya Capital Housing ETF'>HOMZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445771\" data-linked=\"Homebuilders slide after housing starts disappoint\" data-tweet=\"$ITB $HOV $DHI - Homebuilders slide after housing starts disappoint https://seekingalpha.com/news/3445771-homebuilders-slide-after-housing-starts-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3445771-homebuilders-slide-after-housing-starts-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445767\" data-ts=\"1553616159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445767-amira-nature-foods-and-alkaline-water-company-in-consumer-gainers-kandi-technologies-leads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amira Nature Foods and The Alkaline Water Company in consumer gainers; Kandi Technologies leads the losers</a></h4><ul><li><b>Gainers: </b>Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"green\">+17%</font>. The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) <font color=\"red\">-15%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-8%</font>. Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) <font color=\"red\">-7%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445767\" data-linked=\"Amira Nature Foods and The Alkaline Water Company in consumer gainers; Kandi Technologies leads the losers\" data-tweet=\"$ANFI $WTER $KNDI - Amira Nature Foods and The Alkaline Water Company in consumer gainers; Kandi Technologies leads the losers https://seekingalpha.com/news/3445767-amira-nature-foods-and-alkaline-water-company-in-consumer-gainers-kandi-technologies-leads?source=tweet\" data-url=\"https://seekingalpha.com/news/3445767-amira-nature-foods-and-alkaline-water-company-in-consumer-gainers-kandi-technologies-leads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445757\" data-ts=\"1553615063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORN\" target=\"_blank\">ORN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445757-orion-groupminus-5-on-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orion Group -5% on Q4 earnings miss</a></h4><ul><li>Orion Group (<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a> <font color=\"red\">-5.3%</font>) reported Q4 revenue decrease of 38.8% Y/Y to $99.2M, reflecting continued negative weather patterns in Texas, and adjustments of estimates on certain projects.</li><li>Segment revenues: Marine $36.9M (-58% Y/Y); and Concrete $62.3M (-15.9% Y/Y).</li><li>Q4 Gross loss was $20.9M, and gross margin was -21%, compared to 17.1% a year ago.</li><li>Q4 Operating loss was $104.8M compared to income of $10.8M Q4 2017, loss reflects the contract adjustments of $22.8M, the goodwill impairment charge of $69.5M, and the $4.3M non-cash charge for reserves on disputed accounts receivables.</li><li>Q4 Adj. EBITDA decreased by 86.2% Y/Y to $2.48M; and margin <font color=\"red\">declined by 855 bps</font> to 2.5%.</li><li>Segment Adj. EBITDA margins: Marine 15.3% <font color=\"red\">down by 210 bps</font>; and Concrete -5.1% compared to 3.5% a year ago.</li><li>SG&amp;A expenses were $15.21M a decrease of 10.5% Y/Y.</li><li>Backlog of work under contract as of December 31, 2018 was $441M (+22.2% Y/Y).</li><li>Net cash provided by operating activities YTD was $21.93M, compared to $34.13M a year ago. Cash and cash equivalents at end of year was at $8.68M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445567-orion-group-misses-0_14-misses-revenue\" target=\"_blank\">Orion Group misses by $0.14, misses on revenue</a> (March 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445589-orion-group-appoints-interim-coo\" target=\"_blank\">Orion Group appoints interim COO</a> (March 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445757\" data-linked=\"Orion Group -5% on Q4 earnings miss\" data-tweet=\"$ORN - Orion Group -5% on Q4 earnings miss https://seekingalpha.com/news/3445757-orion-groupminus-5-on-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3445757-orion-groupminus-5-on-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445756\" data-ts=\"1553614850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445756-viacom-affirms-guidance-for-domestic-affiliate-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom affirms guidance for domestic affiliate revenue growth</a></h4><ul>   <li>With its high-stakes stand-off with AT&amp;T settled, Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color=\"green\">+5.5%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color=\"green\">+9.2%</font>) has <a href=\"https://seekingalpha.com/filing/4418001\" target=\"_blank\">reaffirmed guidance</a> for full-year domestic affiliate revenue growth.</li>    <li>The company noted its reaffirmed guidance in a Reg FD disclosure.</li>    <li>The dispute with AT&amp;T, which headed into weekend negotiations before being settled, put $1B in carriage fees at risk.</li>    <li>On its <a href=\"https://seekingalpha.com/article/4238115-viacom-inc-2019-q1-results-earnings-call-slides\" target=\"_blank\">earnings call</a> in early February, the company said it continued to expect \"low single digit\" growth in full-year domestic affiliate revenues.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445728-report-carriage-dispute-viacom-cbs-reheat-merger-talk\" target=\"_blank\">Report: Carriage dispute over, Viacom and CBS reheat merger talk</a> (Mar. 26 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445756\" data-linked=\"Viacom affirms guidance for domestic affiliate revenue growth\" data-tweet=\"$VIA $VIAB - Viacom affirms guidance for domestic affiliate revenue growth https://seekingalpha.com/news/3445756-viacom-affirms-guidance-for-domestic-affiliate-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3445756-viacom-affirms-guidance-for-domestic-affiliate-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445755\" data-ts=\"1553614831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445755-can-fites-namodenoson-flunks-mid-stage-liver-cancer-study-shares-down-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite&#39;s namodenoson flunks mid-stage liver cancer study; shares down 26%</a></h4><ul><li>Thinly traded nano cap Can-Fite BioPharma (<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a> <font color=\"red\">-25.6%</font>) slumps on more than triple normal volume after it <a href=\"https://seekingalpha.com/pr/17454707-can-fite-announces-phase-ii-advanced-liver-cancer-top-line-results-orphan-fast-track-drug\" target=\"_blank\">reported</a> unsuccessful results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02128958?lead=can-fite&amp;phase=1&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating namodenoson in patients with advanced liver cancer.</li><li>The study failed to achieve the primary endpoint of overall survival &#40;OS&#41;. Specifically, median OS in the treatment group was 4.1 months compared to 4.3 months for placebo.</li><li>A treatment effect was observed in a subgroup of patients with a stage of advanced liver cancer categorized as CPB7 who had failed to adequately respond to initial treatment with Bayer's <a href=\"https://www.nexavar-us.com/\" target=\"_blank\">Nexavar </a>(sorafenib). Median OS in this group was 6.8 months versus 4.3 months for placebo.</li><li>The company remains undeterred by the mixed results, saying the data \"strongly support\" advancement into Phase 3 development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445755\" data-linked=\"Can-Fite&#39;s namodenoson flunks mid-stage liver cancer study; shares down 26%\" data-tweet=\"$CANF - Can-Fite&#39;s namodenoson flunks mid-stage liver cancer study; shares down 26% https://seekingalpha.com/news/3445755-can-fites-namodenoson-flunks-mid-stage-liver-cancer-study-shares-down-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3445755-can-fites-namodenoson-flunks-mid-stage-liver-cancer-study-shares-down-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445754\" data-ts=\"1553614639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445754-wells-fargo-stays-positive-on-cruise-line-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo stays positive on cruise line stocks</a></h4><ul> <li>Wells Fargo remains \"constructive\" on the cruise line industry, despite the soft profit guidance issued earlier today by Carnival (<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a> <font color='red'>-8.1%</font>).</li> <li>Analyst Tim Conder thinks Carnival's weakness is tied to the unfavorable fuel/FX impact on its bottom line and concerns over pricing with the Costa brand.</li> <li>Conder sees no read through for Norwegian Cruise Line Holdings (<a href='https://seekingalpha.com/symbol/NCLH' title='Norwegian Cruise Line Holdings Ltd.'>NCLH</a> <font color='red'>-1%</font>) and Royal Caribbean (<a href='https://seekingalpha.com/symbol/RCL' title='Royal Caribbean Cruises Ltd.'>RCL</a> <font color='red'>-0.4%</font>). \"We believe RCL &amp; NCLH continue to relatively outperform,\" he writes. All three cruise line stocks are still rated at Outperform by Wells Fargo.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445679-carnival-beats-0_05-beats-revenue\" target=\"_blank\">Carnival beats by $0.05, beats on revenue</a> (March 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445691-carnival-minus-7-percent-guidance-disappoints\" target=\"_blank\">Carnival -7% after guidance disappoints</a> (March 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445754\" data-linked=\"Wells Fargo stays positive on cruise line stocks\" data-tweet=\"$CCL $NCLH $RCL - Wells Fargo stays positive on cruise line stocks https://seekingalpha.com/news/3445754-wells-fargo-stays-positive-on-cruise-line-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3445754-wells-fargo-stays-positive-on-cruise-line-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445751\" data-ts=\"1553614189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445751-gannett-files-proxy-statement-amid-control-fight-mng\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gannett files proxy statement amid control fight with MNG</a></h4><ul>   <li>Gannett (<a href=\"http://seekingalpha.com/symbol/GCI\" target=\"_blank\">GCI</a> <font color=\"green\">+1.6%</font>) has filed a definitive <a href=\"https://seekingalpha.com/pr/17455096-gannett-files-definitive-proxy-statement-mails-letter-shareholders\" target=\"_blank\">proxy statement</a> as it faces a hostile pursuit from MNG/Digital First.</li>    <li>It's urging a vote for eight independent director nominees, vs. a slate being presented by MNG and its majority owner, Alden Global Capital.</li>    <li>MNG is looking to take control \"through a problematic, two-pronged approach\" of demanding a sale and then presenting a rival slate, Gannett says.</li>    <li>\"Your board believes that MNG\u2019s nominees would not bring any additive skills or experience to the Gannett board,\" the company says. \"Additionally, your board is cognizant of Alden\u2019s history of engaging in transactions that have destroyed value while lining the pockets of Alden and its affiliates, including, at MNG, stripping newspapers of certain assets while paying Alden generous management fees.\"</li>    <li>Gannett also says all six of MNG's candidates exhibit \"obvious and significant\" conflicts of interest.</li>    <li>The company's annual meeting is set for 8:30 a.m. ET on May 16.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445751\" data-linked=\"Gannett files proxy statement amid control fight with MNG\" data-tweet=\"$GCI - Gannett files proxy statement amid control fight with MNG https://seekingalpha.com/news/3445751-gannett-files-proxy-statement-amid-control-fight-mng?source=tweet\" data-url=\"https://seekingalpha.com/news/3445751-gannett-files-proxy-statement-amid-control-fight-mng\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445748\" data-ts=\"1553613465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOXL\" target=\"_blank\">BOXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445748-boxlightplus-5_8-on-new-mimio-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boxlight +5.8% on new Mimio partnership</a></h4><ul><li>Bahwan CyberTek <a href=\"https://seekingalpha.com/pr/17455024-bahwan-cybertek-boxlight-mimio-announce-exclusive-partnership\" target=\"_blank\">will bring</a> Boxlight (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) Mimio classroom solutions to the Middle East under a new partnership and will have exclusive rights to the Oman market.</li><li>Boxlight Mimio is available in over 1M classrooms around the world.</li><li>BOXL shares are <font color=\"green\">up 5.8%</font> to $2.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445748\" data-linked=\"Boxlight +5.8% on new Mimio partnership\" data-tweet=\"$BOXL - Boxlight +5.8% on new Mimio partnership https://seekingalpha.com/news/3445748-boxlightplus-5_8-on-new-mimio-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3445748-boxlightplus-5_8-on-new-mimio-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445746\" data-ts=\"1553613330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445746-opgen-prices-stock-offering-0_60-shares-down-37\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpGen prices stock offering at $0.60; shares down 37%</a></h4><ul><li>Thinly traded nano cap OpGen (<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen, Inc.'>OPGN</a> <font color=\"red\">-37.3%</font>) is down on a 24x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17455310-opgen-announces-pricing-5_4-million-public-offering-common-stock\" target=\"_blank\">public offering</a> of 9M common shares at $0.60 per share. Underwriters over-allotment is an additional 1.35M shares. Closing date is March 28.</li><li>Yesterday's close was $0.88.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445746\" data-linked=\"OpGen prices stock offering at $0.60; shares down 37%\" data-tweet=\"$OPGN - OpGen prices stock offering at $0.60; shares down 37% https://seekingalpha.com/news/3445746-opgen-prices-stock-offering-0_60-shares-down-37?source=tweet\" data-url=\"https://seekingalpha.com/news/3445746-opgen-prices-stock-offering-0_60-shares-down-37\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445745\" data-ts=\"1553613298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGT\" target=\"_blank\">ALGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445745-allegiant-travel-higher-after-macquarie-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegiant Travel higher after Macquarie lift</a></h4><ul> <li>Macquarie upgrades Allegiant Travel (<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a> <font color='green'>+1.7%</font>) to an Outperform rating from Neutral.</li> <li>The investment firm points to solid fare trends.</li> <li>Macquarie's price target on ALGT of $149 reps +20% upside potential for shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445745\" data-linked=\"Allegiant Travel higher after Macquarie lift\" data-tweet=\"$ALGT - Allegiant Travel higher after Macquarie lift https://seekingalpha.com/news/3445745-allegiant-travel-higher-after-macquarie-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3445745-allegiant-travel-higher-after-macquarie-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445742\" data-ts=\"1553612769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445742-biocept-and-atossa-genetics-among-healthcare-gainers-quorum-health-and-can-fite-biopharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept and Atossa Genetics among healthcare gainers; Quorum Health and Can-Fite BioPharma among losers</a></h4><ul><li><b>Gainers: </b>Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"green\">+48%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"green\">+17%</font>. Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"green\">+12% </font>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics, Inc.'>ADMA</a>) <font color=\"green\">+11%</font>. Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"red\">-17%</font>. Correvio Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CORV' title='Correvio Pharma Corp.'>CORV</a>) <font color=\"red\">-13%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-11%</font>. Neogen (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOG' title='Neogen Corporation'>NEOG</a>) <font color=\"red\">-11%</font>. Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics, Inc.'>AXSM</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445742\" data-linked=\"Biocept and Atossa Genetics among healthcare gainers; Quorum Health and Can-Fite BioPharma among losers\" data-tweet=\"$ALDX $BIOC $ATOS - Biocept and Atossa Genetics among healthcare gainers; Quorum Health and Can-Fite BioPharma among losers https://seekingalpha.com/news/3445742-biocept-and-atossa-genetics-among-healthcare-gainers-quorum-health-and-can-fite-biopharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3445742-biocept-and-atossa-genetics-among-healthcare-gainers-quorum-health-and-can-fite-biopharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445740\" data-ts=\"1553612042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445740-china-scales-back-ev-subsidies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China scales back EV subsidies</a></h4><ul> <li>The Chinese government says it will <a href=\"https://www.bloomberg.com/news/articles/2019-03-26/china-scales-back-subsidies-for-electric-cars-to-spur-innovation\" target=\"_blank\">lower</a> the highest subsidy for new energy vehicles by 50% as part of a plan scale back completely after 2020.</li> <li>The Ministry of Finance lists the new subsidy for pure battery electric cars with a driving range of +250 miles to 25K yuan ($3.7K) per vehicle from 50K yuan. Local governments are also being asked to pull back on subsidies as the Ministry hopes local manufacturers ramp up innovation to keep competitive.</li> <li>Even with the development widely anticipated, companies that could be impacted by the new subsidy policy include Nio (<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a> <font color='red'>-3.9%</font>), Great Wall Motors (<a href='https://seekingalpha.com/symbol/GWLLF' title='Great Wall Motor Company Limited'>OTCPK:GWLLF</a>, <a href='https://seekingalpha.com/symbol/GWLLY' title='Great Wall Motor Company Limited'>OTCPK:GWLLY</a>), BYD (<a href='https://seekingalpha.com/symbol/BYDDY' title='BYD Company Limited'>OTCPK:BYDDY</a>, <a href='https://seekingalpha.com/symbol/BYDDF' title='BYD Company Limited'>OTCPK:BYDDF</a>), Geely Automobile (<a href='https://seekingalpha.com/symbol/GELYY' title='Geely Automobile Holdings Limited'>OTCPK:GELYY</a>), Kandi Technologies (<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='red'>-10.3%</font>), Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>), Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+2.7%</font>), Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='green'>+2.2%</font>) and Dongfeng Motor (<a href='https://seekingalpha.com/symbol/DNFGY' title='Dongfeng Motor Group Company Limited'>OTCPK:DNFGY</a>).   </li> </ul><div class=\"tiny-share-widget\" data-id=\"3445740\" data-linked=\"China scales back EV subsidies\" data-tweet=\"$NIO $GWLLF $GWLLY - China scales back EV subsidies https://seekingalpha.com/news/3445740-china-scales-back-ev-subsidies?source=tweet\" data-url=\"https://seekingalpha.com/news/3445740-china-scales-back-ev-subsidies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>309&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445739\" data-ts=\"1553612016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445739-citi-roku-wont-see-much-upside-from-new-apple-tv-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi: Roku won&#39;t see much upside from new Apple TV service</a></h4><ul>    <li>Roku's CEO, Anthony Wood, was in <a href=\"https://seekingalpha.com/news/3445434-roku-plus-4_4-percent-ceo-standing-apple-event\" target=\"_blank\">Apple's staging area</a> at yesterday's big Apple TV announcement event, but after a launch short on details, Citi says Roku won't see much upside.</li>    <li><a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a> is <font color=\"red\">down 2.4%</font>; shares <font color=\"green\">rose 4.7%</font> yesterday.</li>    <li>The company actually faces a \"slight incremental negative,\" Citi's Mark May writes. \"The inclusion of the Apple TV app on Roku devices alone will not drive meaningful incremental direct ad revenue,\" and because Apple's App allows access to service like Hulu and Amazon Prime, it could \"cannibalize time spent on other apps on Roku where it is able to monetize ad inventory.\" (h/t Bloomberg)</li>    <li>Citi is Neutral on Roku with a price target of $53, implying 19% downside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445739\" data-linked=\"Citi: Roku won&#39;t see much upside from new Apple TV service\" data-tweet=\"$ROKU - Citi: Roku won&#39;t see much upside from new Apple TV service https://seekingalpha.com/news/3445739-citi-roku-wont-see-much-upside-from-new-apple-tv-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3445739-citi-roku-wont-see-much-upside-from-new-apple-tv-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445734\" data-ts=\"1553611711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAEX\" target=\"_blank\">SAEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445734-saexploration-down-6-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAExploration down 6% post Q4 results</a></h4><ul><li>SAExploration (<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color=\"red\">-6.5%</font>) reported Q4 revenue growth of 428.6% Y/Y to $25.6M, the increase was due to an increase in the number of projects in North America.</li><li>Revenue by region: North America $21.47M (+91.8% Y/Y); South America $232k (+9.3% Y/Y); and Asia Pacific $3.89M.</li><li>Q4 Adj. gross margin recovered to 5.2% from -16.8% a year ago.</li><li>Q4 operating loss was $15.05M, compared to $10.24M a year ago.</li><li>Adj. EBITDA was negative $8.04M, compared to negative $6.82M a year ago.</li><li>Company said both adjusted gross profit and adjusted EBITDA in Q4 were negatively impacted by less favorable pricing when taking into account the fixed costs involved in SAE\u2019s projects.</li><li>SG&amp;A expenses were $12.93M up by 92.6% Y/Y.</li><li>Contracted backlog of $184.9M, as of December 31, 2018, does not include $60M of new projects, and $570.7M of bids outstanding.</li><li>Company had cash and cash equivalents of $7.2M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445509-saexploration-reports-q4-results\" target=\"_blank\">SAExploration reports Q4 results</a> (March 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445734\" data-linked=\"SAExploration down 6% post Q4 results\" data-tweet=\"$SAEX - SAExploration down 6% post Q4 results https://seekingalpha.com/news/3445734-saexploration-down-6-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3445734-saexploration-down-6-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445731\" data-ts=\"1553610799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFIN\" target=\"_blank\">MFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445731-medallion-financial-closes-on-30m-private-placement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medallion Financial closes on $30M private placement</a></h4><ul><li>Medallion Financial (<a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color='green'>+1.9%</font>) <a href=\"https://seekingalpha.com/pr/17455240-medallion-financial-announces-completion-private-placement-30-million-senior-unsecured-notes\" target=\"_blank\">completes</a> a private placement of $30M of fixed-rate unsecured notes to certain institutional investors.</li><li>The notes will mature on March 22, 2024 and bear a fixed interest rate of 8.25% per year, paid semi-annually, starting Sept. 22, 2019.</li><li>Proceeds to pay down some existing outstanding debt and to be used for other general corporate purposes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3438067-medallion-financial-q4-swings-profit\" target=\"_blank\">Medallion Financial Q4 swings to profit</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445731\" data-linked=\"Medallion Financial closes on $30M private placement\" data-tweet=\"$MFIN - Medallion Financial closes on $30M private placement https://seekingalpha.com/news/3445731-medallion-financial-closes-on-30m-private-placement?source=tweet\" data-url=\"https://seekingalpha.com/news/3445731-medallion-financial-closes-on-30m-private-placement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445728\" data-ts=\"1553610547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445728-report-carriage-dispute-over-viacom-and-cbs-reheat-merger-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Carriage dispute over, Viacom and CBS reheat merger talk</a></h4><ul>     <li>With a carriage dispute with DirecTV <a href=\"https://seekingalpha.com/news/3445288-viacom-plus-5-percent-renewing-contract-and-t-avoiding-directv-blackout\" target=\"_blank\">safely settled</a>, Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color=\"green\">+3.6%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color=\"green\">+5%</font>) is <a href=\"https://nypost.com/2019/03/25/cbs-viacom-reignite-merger-talks-centering-on-who-will-be-ceo/\" target=\"_blank\">set to resume re-merger talks</a> with CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color=\"green\">+2.7%</font>), the <i>New York Post</i> reports.</li>    <li>Viacom's channels (including MTV, Comedy Central and Nickelodeon) are safely back on AT&amp;T's platforms, and now CBS independent directors are clear to tell the rest of the board in the next couple of weeks that it's time to take another shot at the merger, according to the report.</li>    <li>Viacom would be asked to hand over a premium in a share swap because its shares have fallen further than CBS in the past 12 months.</li>    <li>The other holdover issue is who would be CEO of the combined company, though times have changed since former CBS Chairman/CEO Les Moonves was pulling weight in the merger talks.</li><li>Without him in the picture, it looks to settle on Viacom chief Bob Bakish or Moonves lieutenant (and CBS interim CEO) Joe Ianniello, with Bakish as an apparent front-runner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445728\" data-linked=\"Report: Carriage dispute over, Viacom and CBS reheat merger talk\" data-tweet=\"$VIA $VIAB $VIAC - Report: Carriage dispute over, Viacom and CBS reheat merger talk https://seekingalpha.com/news/3445728-report-carriage-dispute-over-viacom-and-cbs-reheat-merger-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3445728-report-carriage-dispute-over-viacom-and-cbs-reheat-merger-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445723\" data-ts=\"1553610066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRA\" target=\"_blank\">NTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445723-natera-up-1-on-collaboration-aml-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natera up 1% on collaboration with AML Therapeutics</a></h4><ul><li>Natera (<a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a> <font color=\"green\">+0.7%</font>) perks up on light volume on the heels of its announced <a href=\"https://seekingalpha.com/pr/17454967-natera-partner-amal-therapeutics-clinical-trial-using-signatera-mrd-test-assess-treatment\" target=\"_blank\">collaboration </a>with AML Therapeutics in a clinical trial evaluating the latter's therapeutic cancer vaccine candidate ATP128 in patients with stage IV colorectal cancer.</li><li>The companies will evaluate Natera's Signatera molecular residual disease test as a biomarker to assess responses to ATP128.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445723\" data-linked=\"Natera up 1% on collaboration with AML Therapeutics\" data-tweet=\"$NTRA - Natera up 1% on collaboration with AML Therapeutics https://seekingalpha.com/news/3445723-natera-up-1-on-collaboration-aml-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3445723-natera-up-1-on-collaboration-aml-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445722\" data-ts=\"1553610040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445722-vale-rises-btg-santander-reiterate-buy-after-q4-production-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale rises as BTG, Santander reiterate Buy after Q4 production report</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"green\">+1.6%</font>) pops higher in early trade after reporting <a href=\"https://seekingalpha.com/news/3445673-vale-sees-8-percent-gain-q4-iron-ore-production\" target=\"_blank\">Q4 iron ore production</a> rose a healthy 8% Y/Y to 101M tons.</li><li>Q4 data came in within the company's guidance and the share of its premium products continued to rise, Santander analyst Gustavo Allevato says, maintaining a Buy rating on the stock and adding that lower iron ore supply from Vale should continue to support prices in the short term.</li><li>Vale presented an \"eventful\" Q4 production report but with limited visibility of full-year iron ore output, BTG Pactual analysts Leonardo Correa and Gerard Roure say; the firm has a Buy rating on Vale due to valuation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445722\" data-linked=\"Vale rises as BTG, Santander reiterate Buy after Q4 production report\" data-tweet=\"$VALE - Vale rises as BTG, Santander reiterate Buy after Q4 production report https://seekingalpha.com/news/3445722-vale-rises-btg-santander-reiterate-buy-after-q4-production-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3445722-vale-rises-btg-santander-reiterate-buy-after-q4-production-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445720\" data-ts=\"1553609454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445720-monster-beverage-gains-after-guggenheim-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage gains after Guggenheim nod</a></h4><ul> <li>Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corporation'>MNST</a> <font color='green'>+1.1%</font>) tracks higher after Guggenheim calls the company's expansion the most attractive food and beverage growth model.</li> <li>The firm keeps a Buy rating and price target of $70 on Monster. The 52-week high for Monster is $66.38.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445720\" data-linked=\"Monster Beverage gains after Guggenheim nod\" data-tweet=\"$MNST - Monster Beverage gains after Guggenheim nod https://seekingalpha.com/news/3445720-monster-beverage-gains-after-guggenheim-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3445720-monster-beverage-gains-after-guggenheim-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445718\" data-ts=\"1553609366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORMP\" target=\"_blank\">ORMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445718-oramed-up-11-on-oral-insulin-studies-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oramed up 11% on oral insulin studies in China</a></h4><ul><li>Thinly traded nano cap Oramed Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color=\"green\">+10.5%</font>) is up on an 11x surge in volume, albeit on turnover of only 410K shares, in response to <a href=\"https://seekingalpha.com/pr/17455117-chinese-regulatory-authority-nmpa-approves-ind-application-orameds-oral-insulin-capsules\" target=\"_blank\">regulatory sign-off</a> in China for clinical trials of its oral insulin.</li><li>Commercialization partner Hefei Tianhui Incubator of Technologies Co., Ltd. will manage the studies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445718\" data-linked=\"Oramed up 11% on oral insulin studies in China\" data-tweet=\"$ORMP - Oramed up 11% on oral insulin studies in China https://seekingalpha.com/news/3445718-oramed-up-11-on-oral-insulin-studies-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3445718-oramed-up-11-on-oral-insulin-studies-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445717\" data-ts=\"1553609312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445717-oil-pops-above-60-focus-returns-to-tight-global-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil pops above $60 as focus returns to tight global supply</a></h4><ul><li><a href=\"https://www.cnbc.com/2019/03/26/oil-market-opec-supply-cuts-us-sanctions-in-focus.html\" target=\"_blank\">U.S. crude oil breaks above $60/bbl</a>, as market participants regain focus on the tight supply situation and away from concerns about weaker demand from a potential economic slowdown; WTI <font color=\"green\">+2.4%</font> to $60.27/bbl, Brent <font color=\"green\">+1.4%</font> at $68.14/bbl.</li><li>\u201cLower OPEC+ production due to improving compliance and renewed power outages in Venezuela likely triggering further disruptions are <a href=\"https://www.wsj.com/articles/oil-prices-climb-on-tightening-supply-11553597567\" target=\"_blank\">supporting oil prices</a>,\u201d says UBS commodities analyst Giovanni Staunovo.</li><li>\u201cAs long as OPEC\u2019s output remains depressed and global oil demand and oil demand growth stay around the current level, money managers will likely keep investing in oil, thus supporting the price,\u201d says Tamas Varga of PVM Oil Associates.</li><li>Oil and gas stocks are posting strong early gains: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color=\"green\">+1.3%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+1.3%</font>, <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color=\"green\">+1.5%</font>, <a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color=\"green\">+1.5%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"green\">+2.5%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+4.7%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"green\">+2.7%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+2.9%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+3%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"green\">+2.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445717\" data-linked=\"Oil pops above $60 as focus returns to tight global supply\" data-tweet=\"$XOM $CVX $BP - Oil pops above $60 as focus returns to tight global supply https://seekingalpha.com/news/3445717-oil-pops-above-60-focus-returns-to-tight-global-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3445717-oil-pops-above-60-focus-returns-to-tight-global-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445710\" data-ts=\"1553608654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445710-t-authorized-to-operate-on-federal-eis-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T authorized to operate on federal EIS contract</a></h4><ul>   <li>AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+1.6%</font>) has received authority to operate under the General Service Administration's Enterprise Infrastructure Solutions contract, joining fellow carrier Verizon.</li>    <li>That means it will have the chance to compete for federal government business on the $50B telecom contract vehicle, which replaces older contract vehicles.</li>    <li>\u201cWe\u2019re authorized and best equipped to help agencies modernize for an ever-evolving connected and digital future that includes 5G services,\u201d says AT&amp;T's Chris Smith.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445710\" data-linked=\"AT&amp;T authorized to operate on federal EIS contract\" data-tweet=\"$T - AT&amp;T authorized to operate on federal EIS contract https://seekingalpha.com/news/3445710-t-authorized-to-operate-on-federal-eis-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3445710-t-authorized-to-operate-on-federal-eis-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445697\" data-ts=\"1553607155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445697-j-and-j-files-u-s-marketing-application-for-expanded-use-of-darzalex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J files U.S. marketing application for expanded use of Darzalex</a></h4><ul><li>Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+0.7%</font>) unit Janssen Biotech has filed a supplemental <a href=\"https://seekingalpha.com/pr/17455376-genmab-announces-submission-supplemental-biologics-license-application-fda-daratumumab\" target=\"_blank\">marketing application</a> with the FDA seeking approval to use DARZALEX (daratumumab), combined with Takeda's Velcade (bortezomib), thalidomide and dexamethasone, to treat newly diagnosed multiple myeloma patients who are candidates for autologous stem cell transplantation.</li><li>Janssen in-licensed daratumumab from Genmab A/S (<a href='https://seekingalpha.com/symbol/GNMSF' title='Genmab A/S'>OTCPK:GNMSF</a>) in August 2012.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445697\" data-linked=\"J&amp;J files U.S. marketing application for expanded use of Darzalex\" data-tweet=\"$JNJ $GNMSF $GMXAY - J&amp;J files U.S. marketing application for expanded use of Darzalex https://seekingalpha.com/news/3445697-j-and-j-files-u-s-marketing-application-for-expanded-use-of-darzalex?source=tweet\" data-url=\"https://seekingalpha.com/news/3445697-j-and-j-files-u-s-marketing-application-for-expanded-use-of-darzalex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445693\" data-ts=\"1553606953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445693-trade-desk-officially-launches-programmatic-buying-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk officially launches programmatic buying in China</a></h4><ul>   <li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) has given its programmatic ad platform an <a href=\"https://seekingalpha.com/pr/17454606-trade-desk-opens-doors-global-advertisers-reach-audiences-china\" target=\"_blank\">official launch in China</a>.</li>    <li>The company opened the program in beta late last year, and says it has since delivered multichannel campaigns there for brands in multiple sectors, including hospitality, luxury retail, education, food and beverage, and biotech.</li>    <li>Shares are <font color=\"green\">up 2.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445693\" data-linked=\"Trade Desk officially launches programmatic buying in China\" data-tweet=\"$TTD - Trade Desk officially launches programmatic buying in China https://seekingalpha.com/news/3445693-trade-desk-officially-launches-programmatic-buying-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3445693-trade-desk-officially-launches-programmatic-buying-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445691\" data-ts=\"1553606885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445691-carnivalminus-7-after-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival -7% after guidance disappoints</a></h4><ul> <li>Carnival (NYSE:<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a>) is <font color=\"red\">down 6.62%</font> in premarket trading after setting guidance below expectations.</li> <li>The cruise line operator expects Q2 EPS of $0.56 to $0.60 vs. $0.73 consensus and full-year EPS of $4.35 to $4.55 vs. $4.77 consensus and $4.50 to $4.80 prior. The company points to changes in fuel prices and foreign exchange rates in setting the outlook.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3445691\" data-linked=\"Carnival -7% after guidance disappoints\" data-tweet=\"$CCL - Carnival -7% after guidance disappoints https://seekingalpha.com/news/3445691-carnivalminus-7-after-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3445691-carnivalminus-7-after-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445690\" data-ts=\"1553606742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445690-bbby-srne-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY, SRNE among premarket gainers</a></h4><ul><li>Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"green\">+59% </font>on positive reproxalap <a href=\"https://seekingalpha.com/news/3445623-aldeyra-60-percent-premarket-positive-reproxalap-data\" target=\"_blank\">data</a>.</li><li>Hunter Maritime Acquisition (NASDAQ:<a href='https://seekingalpha.com/symbol/HUNT' title='Hunter Maritime Acquisition Corp.'>HUNT</a>) <font color=\"green\">+57%</font>.</li><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+22%</font> as an activist group is <a href=\"https://seekingalpha.com/news/3445614-bed-bath-and-beyond-plus-16-percent-activists-gearing\" target=\"_blank\">targeting</a> turning over the company's entire board.</li><li>Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/pr/17455060-atossa-genetics-announces-institutional-review-board-approval-oral-endoxifen-post-mastectomy\" target=\"_blank\">approval</a> of oral Endoxifen as post-mastectomy treatment for a U.S. breast cancer patient.</li><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <font color=\"green\">+13%</font> <a href=\"https://seekingalpha.com/pr/17454787-moleculin-announces-positive-interim-results-first-cohort-phase-1-2-clinical-studies\" target=\"_blank\">positive</a> interim safety and efficacy data from two ongoing open label, single arm Phase 1/2 studies of Annamycin.</li><li>Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3445634-amira-nature-foods-announces-increase-previously-announced-contract-value\" target=\"_blank\">increase</a> in previously announced contract value.</li><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics, Inc.'>PTI</a>) <font color=\"green\">+7%</font> <a href=\"https://seekingalpha.com/news/3445329-proteostasis-48-percent-premarket-disappointing-data-cf-candidates\" target=\"_blank\">bounces</a> back after yesterday's fall.</li><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3445662-biocept-13-percent-premarket-expansion-urology\" target=\"_blank\">expansion</a> into urology.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+6%</font>.</li><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/pr/17455054-scilex-holding-subsidiary-sorrento-therapeutics-announces-phase-2-trial-results-leading\" target=\"_blank\">announcing</a> Phase 2 Trial Results for its Leading SP-102 Program</li></ul><div class=\"tiny-share-widget\" data-id=\"3445690\" data-linked=\"BBBY, SRNE among premarket gainers\" data-tweet=\"$ALDX $HUNT $BBBY - BBBY, SRNE among premarket gainers https://seekingalpha.com/news/3445690-bbby-srne-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445690-bbby-srne-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445688\" data-ts=\"1553606683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445688-adobe-microsoft-team-to-take-on-salesforce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe, Microsoft team to take on Salesforce</a></h4><ul><li>Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Inc.'>ADBE</a>) and Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) are <a href=\"https://seekingalpha.com/pr/17455183-adobe-microsoft-linkedin-join-forces-accelerate-account-based-experiences\" target=\"_blank\">teaming up </a>to mutually bolster sales and marketing software capabilities to take on Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a>).</li><li>A new LinkedIn integration will make it easier for Adobe product users to find potential customers for business goods. If the LinkedIn ad campaign succeeds in finding buyers, the customer can then use Microsoft's Dynamics 365 sales software to close the deals.</li><li>Last year, Adobe acquired B2B software firm Marketo for $4.75B and paved the way for the LinkedIn partnership.</li><li>Adobe shares are <font color=\"green\">up 0.8%</font> pre-market, Microsoft <font color=\"green\">gains 0.5%</font>, and Salesforce is <font color=\"green\">up 1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445688\" data-linked=\"Adobe, Microsoft team to take on Salesforce\" data-tweet=\"$ADBE $MSFT $ADBE - Adobe, Microsoft team to take on Salesforce https://seekingalpha.com/news/3445688-adobe-microsoft-team-to-take-on-salesforce?source=tweet\" data-url=\"https://seekingalpha.com/news/3445688-adobe-microsoft-team-to-take-on-salesforce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445685\" data-ts=\"1553606589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445685-neptuneplus-6-on-initiating-production-and-shipping-of-cannabis-extracts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune +6% on initiating production and shipping of cannabis extracts</a></h4><ul> <li>Neptune Wellness Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) has <a href=\"https://seekingalpha.com/pr/17454796-neptune-begins-commercial-production-shipping-cannabis-extracts\" target=\"_blank\">completed</a> initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec.</li>                  <li>Upon successful analysis and testing, the products are now being shipped and invoiced.</li>  <li>The completion of investments for installation of Phase 2 ethanol-based extraction equipment remains on track for the end of March, with operations planned to ramp up total annual processing capacity of 200,000 kg by July, pending regulatory approvals.</li> <li>Neptune has also initiated, planning for the third phase of its capacity expansion investments, which will bring its total extraction capacity to 6,000,000 kg.</li><li>Shares are up <font color=\"green\">6%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3445685\" data-linked=\"Neptune +6% on initiating production and shipping of cannabis extracts\" data-tweet=\"$NEPT - Neptune +6% on initiating production and shipping of cannabis extracts https://seekingalpha.com/news/3445685-neptuneplus-6-on-initiating-production-and-shipping-of-cannabis-extracts?source=tweet\" data-url=\"https://seekingalpha.com/news/3445685-neptuneplus-6-on-initiating-production-and-shipping-of-cannabis-extracts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445684\" data-ts=\"1553606550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445684-cheetah-mobileminus-2_3-nomura-cautiously-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile -2.3% as Nomura cautiously cuts to Neutral</a></h4><ul>   <li>Cheetah Mobile ADRs (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) are <font color=\"red\">2.3% lower</font> premarket after a downgrade at Nomura, to Neutral.</li>    <li>The firm sees a near-term challenge from international partners suspending business with Cheetah after accusations of fraudulent click injection.</li>    <li>It cut its price target to $7 from $12; <a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> closed yesterday on NYSE at $7.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445684\" data-linked=\"Cheetah Mobile -2.3% as Nomura cautiously cuts to Neutral\" data-tweet=\"$CMCM - Cheetah Mobile -2.3% as Nomura cautiously cuts to Neutral https://seekingalpha.com/news/3445684-cheetah-mobileminus-2_3-nomura-cautiously-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3445684-cheetah-mobileminus-2_3-nomura-cautiously-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445680\" data-ts=\"1553606332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445680-moleculin-reports-mid-stage-data-on-annamycin-in-aml-in-us-and-poland\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin reports mid-stage data on annamycin in AML in US and Poland</a></h4><ul><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <a href=\"https://seekingalpha.com/pr/17454787-moleculin-announces-positive-interim-results-first-cohort-phase-1-2-clinical-studies\" target=\"_blank\">announces</a> positive interim safety and efficacy data from two ongoing Phase 1/2 studies of Annamycin.</li><li>In the first study, being conducted in the US, four patients have completed treatment at 100 mg/m<sup>2</sup> with no significant adverse events, and the study will now proceed to the next higher dose of 120 mg/m<sup>2</sup>.</li><li>The second trial, taking place in Poland, started at a 120 mg/m<sup>2</sup> dose of Annamycin and has treated three patients. The first patient treated received a single course of Annamycin and his bone marrow blasts have reduced from 60% to 11%.</li><li>To date in Poland, one patient experienced grade 2 mucositis and no other adverse events have been reported.</li><li>Trial results for the other two patients treated in Poland will not be known until Q2.</li><li>Shares are up <font color=\"green\">11%</font> premarket.</li>                   </ul><div class=\"tiny-share-widget\" data-id=\"3445680\" data-linked=\"Moleculin reports mid-stage data on annamycin in AML in US and Poland\" data-tweet=\"$MBRX - Moleculin reports mid-stage data on annamycin in AML in US and Poland https://seekingalpha.com/news/3445680-moleculin-reports-mid-stage-data-on-annamycin-in-aml-in-us-and-poland?source=tweet\" data-url=\"https://seekingalpha.com/news/3445680-moleculin-reports-mid-stage-data-on-annamycin-in-aml-in-us-and-poland\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445672\" data-ts=\"1553605833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445672-healthcare-stocks-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare stocks among premarket losers</a></h4><ul><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"red\">-30%</font> on <a href=\"https://seekingalpha.com/pr/17454707-can-fite-announces-phase-ii-advanced-liver-cancer-top-line-results-orphan-fast-track-drug\" target=\"_blank\">announcing</a> phase II advanced liver cancer results for Namodenoson.</li><li>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445672\" data-linked=\"Healthcare stocks among premarket losers\" data-tweet=\"$CANF $MTFB - Healthcare stocks among premarket losers https://seekingalpha.com/news/3445672-healthcare-stocks-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445672-healthcare-stocks-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445663\" data-ts=\"1553605125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITK\" target=\"_blank\">MITK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445663-benchmark-boosts-mitek-on-buyout-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benchmark boosts Mitek on buyout chatter</a></h4><ul><li>Benchmark raises its Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems, Inc.'>MITK</a>) target from $12 to $15 citing buyout chatter.</li><li>The firm thinks Mitek could be worth more than the $12 to $13 per share that Benchmark suggested in October.</li><li>Analyst Mark Schappel cites enterprise multiples increasing since that time, Mitek's story progressing in a positive direction, and the arrival of a new chief executive.</li><li>Mitek shares are <font color=\"green\">up 1.5%</font> pre-market to $12.72.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445663\" data-linked=\"Benchmark boosts Mitek on buyout chatter\" data-tweet=\"$MITK - Benchmark boosts Mitek on buyout chatter https://seekingalpha.com/news/3445663-benchmark-boosts-mitek-on-buyout-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3445663-benchmark-boosts-mitek-on-buyout-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445662\" data-ts=\"1553604970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445662-biocept-up-13-premarket-on-expansion-urology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept up 13% premarket on expansion into urology</a></h4><ul><li>Nano cap Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) is up <font color=\"green\">13%</font> premarket on robust volume following its announced <a href=\"https://seekingalpha.com/pr/17454974-biocept-broadens-commercial-focus-target-selector-liquid-biopsy-platform-include-urology\" target=\"_blank\">expansion</a> of its Empower TC platform into urology.</li><li>Empower TC is now able to perform biomarker tests to aid clinicians and pathologists in diagnosing prostate cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445662\" data-linked=\"Biocept up 13% premarket on expansion into urology\" data-tweet=\"$BIOC - Biocept up 13% premarket on expansion into urology https://seekingalpha.com/news/3445662-biocept-up-13-premarket-on-expansion-urology?source=tweet\" data-url=\"https://seekingalpha.com/news/3445662-biocept-up-13-premarket-on-expansion-urology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445661\" data-ts=\"1553604912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445661-latest-737-max-news-roundup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latest 737 MAX news roundup</a></h4><ul><li>The Civil Aviation Administration of China has reportedly <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-china/china-not-taking-boeing-737-max-8-airworthiness-certificate-applications-idUSKCN1R7188\" target=\"_blank\">suspended</a> the 737 MAX 8's airworthiness certification, which took Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) 15 months to get and finally obtained in October 2017.</li><li>It follows a <a href=\"https://www.nytimes.com/2019/03/25/business/boeing-simulation-error.html\" target=\"_blank\">report</a> from the <i>NYT</i> that suggested \"during flight simulations recreating the problems in the fatal Lion Air crash, pilots discovered that they had less than 40 seconds to override the Boeing 737 MAX MCAS system and avert disaster.\"</li><li>Meanwhile, the preliminary report on the March 10 Ethiopian Airlines 737 MAX crash will very likely be <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-report/preliminary-report-on-ethiopian-airlines-crash-very-likely-released-this-week-transport-ministry-idUSKCN1R70IC\" target=\"_blank\">released</a> this week, according to Ethiopia's transport ministry.</li><li>BA <font color=\"green\">+1%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3445661\" data-linked=\"Latest 737 MAX news roundup\" data-tweet=\"$BA - Latest 737 MAX news roundup https://seekingalpha.com/news/3445661-latest-737-max-news-roundup?source=tweet\" data-url=\"https://seekingalpha.com/news/3445661-latest-737-max-news-roundup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445660\" data-ts=\"1553604898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445660-eyegate-confirms-path-to-de-novo-filing-for-obg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate confirms path to de novo filing for OBG</a></h4><ul> <li>EyeGate Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals, Inc.'>EYEG</a>) has <a href=\"https://seekingalpha.com/pr/17454688-eyegate-confirms-path-de-novo-filing-fda\" target=\"_blank\">met</a> with the FDA regarding its Ocular Bandage Gel (\"OBG\") product and has confirmed its path to a de novo filing.</li><li>The FDA, based on the PRK study has allowed EyeGate to move forward with a pivotal study, which will allow for a de novo filing.</li><li>The Company plans to file the Investigational Device Exemption for initiation of the study in Q2 and to complete it in Q3.</li> <li>EyeGate expects to launch OBG product for the PRK indication in 2020.</li><li>The De Novo pathway is designed for products that have no predicate devices for comparison.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445660\" data-linked=\"EyeGate confirms path to de novo filing for OBG\" data-tweet=\"$EYEG - EyeGate confirms path to de novo filing for OBG https://seekingalpha.com/news/3445660-eyegate-confirms-path-to-de-novo-filing-for-obg?source=tweet\" data-url=\"https://seekingalpha.com/news/3445660-eyegate-confirms-path-to-de-novo-filing-for-obg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445653\" data-ts=\"1553604269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445653-new-age-beveragesplus-5-after-alliance-global-partners-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages +5% after Alliance Global Partners nod</a></h4><ul> <li>Shares of New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) shoot up after Alliance Global Partners starts off coverage with a Buy rating.</li> <li>The research firm's price target of $8.00 reps 52% upside potential from yesterday's closing price.</li> <li>NBEV <font color=\"green\">+4.76%</font> premarket to $5.50 vs. a 52-week trading range of $1.30 to $9.99.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445653\" data-linked=\"New Age Beverages +5% after Alliance Global Partners nod\" data-tweet=\"$NBEV - New Age Beverages +5% after Alliance Global Partners nod https://seekingalpha.com/news/3445653-new-age-beveragesplus-5-after-alliance-global-partners-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3445653-new-age-beveragesplus-5-after-alliance-global-partners-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445649\" data-ts=\"1553603987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445649-inspiremd-reverse-splits-shares-1-50-shares-down-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InspireMD reverse splits shares 1:50; shares down 5% premarket</a></h4><ul> <li>InspireMD's (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) Board of Directors has <a href=\"https://seekingalpha.com/pr/17454727-inspiremd-announces-1minus-50-reverse-stock-split\" target=\"_blank\">approved</a> a 1-for-50 reverse stock split of its common stock, effective after trading closes on March 29.</li><li>Beginning on April 1, the Company\u2019s common stock will trade on a split adjusted basis.</li><li>Shares are down <font color=\"red\">5%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3445649\" data-linked=\"InspireMD reverse splits shares 1:50; shares down 5% premarket\" data-tweet=\"$NSPR - InspireMD reverse splits shares 1:50; shares down 5% premarket https://seekingalpha.com/news/3445649-inspiremd-reverse-splits-shares-1-50-shares-down-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3445649-inspiremd-reverse-splits-shares-1-50-shares-down-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445646\" data-ts=\"1553603588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445646-square-introduces-invoice-app-brings-stand-to-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square introduces invoice app; brings Stand to Japan</a></h4><ul><li>Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>) <a href=\"https://squareup.com/us/en/press/invoices-app\" target=\"_blank\">introduces </a>its invoices app in the U.S., Canada, Japan, the U.K., and Australia.</li><li>App allows sellers to create, manage, and send invoices using mobile devices.</li><li>\u201cWith the Square Invoices app, small business owners are able to get paid remotely and access their funds quickly and securely,\" says Alyssa Henry, seller lead at Square.</li><li>Separately, in Japan, Square <a href=\"https://twitter.com/Square/status/1110503518346141696\" target=\"_blank\">introduces </a>Stand for iPad and its reader for contactless and chip.</li><li>Square <font color=\"green\">gains 1.8%</font> in premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445636-citigroup-expands-consumer-merchant-digital-payments\" target=\"_blank\">Citigroup expands into consumer-to-merchant digital payments</a> (March 26)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/IPAY' title='ETFMG Prime Mobile Payments ETF'>IPAY</a>, <a href='https://seekingalpha.com/symbol/FINX' title='Global X FinTech Thematic ETF'>FINX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445646\" data-linked=\"Square introduces invoice app; brings Stand to Japan\" data-tweet=\"$SQ $SQ $IPAY - Square introduces invoice app; brings Stand to Japan https://seekingalpha.com/news/3445646-square-introduces-invoice-app-brings-stand-to-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3445646-square-introduces-invoice-app-brings-stand-to-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445644\" data-ts=\"1553603517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445644-mcdonalds-ceo-calls-tech-critical-to-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDonald&#39;s CEO calls tech critical to growth</a></h4><ul> <li>McDonald's (NYSE:<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>) acquisition of Dynamic Yield is expected to give it the ability to vary electronic menu boards based on time, weather and regional factors, according to Bloomberg. The flexibility could allow McDonald's operators to respond to customer preferences in real time.</li> <li>The restaurant company fired off the deal after giving Dynamic Yield's technology a test drive last year. The $300M deal is the largest since the company's investment in Chipotle more than 20 years ago.</li> <li>\"Technology is a critical element of our Velocity Growth Plan,\" <a href=\"https://seekingalpha.com/pr/17454447-mcdonalds-acquire-dynamic-yield-will-use-decision-technology-increase-personalization-improve\" target=\"_blank\">notes</a> CEO Steve Easterbrook on the deal. \"With this acquisition, we're expanding both our ability to increase the role technology and data will play in our future and the speed with which we'll be able to implement our vision of creating more personalised experiences for our customers,\" he adds.</li> <li>Shares of McDonald's are <font color=\"green\">up 0.51%</font> in premarket trading to $186.66.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445644\" data-linked=\"McDonald&#39;s CEO calls tech critical to growth\" data-tweet=\"$MCD - McDonald&#39;s CEO calls tech critical to growth https://seekingalpha.com/news/3445644-mcdonalds-ceo-calls-tech-critical-to-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3445644-mcdonalds-ceo-calls-tech-critical-to-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445638\" data-ts=\"1553602953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445638-weatherfordplus-5-after-completing-sale-of-land-drilling-rigs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford +5% after completing sale of land drilling rigs</a></h4><ul><li>Weatherford (NYSE:<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International plc'>WFT</a>) <font color=\"green\">+4.7%</font> pre-market after tumbling 9.2% in yesterday's trade despite an apparent lack of news.</li><li>WFT says it <a href=\"https://seekingalpha.com/pr/17454433-weatherford-completes-sale-land-drilling-rigs\" target=\"_blank\">completed the sale</a> of two land drilling rigs that were relocated in Algeria and delivered two idle land drilling rigs from Iraq, for aggregate proceeds of $32M.</li><li>Also, WFT says it has <a href=\"https://seekingalpha.com/pr/17454683-weatherford-introduces-worlds-first-remote-activated-single-trip-deepwater-completion-system\" target=\"_blank\">brought to market</a> the world's first remote-activated, single-trip deepwater completion system.</li><li>WFT says its TRIP system uses radio-frequency identification technology to deliver 100% percent interventionless operation in both  producer and injector wells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445638\" data-linked=\"Weatherford +5% after completing sale of land drilling rigs\" data-tweet=\"$WFT $WFTIQ - Weatherford +5% after completing sale of land drilling rigs https://seekingalpha.com/news/3445638-weatherfordplus-5-after-completing-sale-of-land-drilling-rigs?source=tweet\" data-url=\"https://seekingalpha.com/news/3445638-weatherfordplus-5-after-completing-sale-of-land-drilling-rigs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445623\" data-ts=\"1553601993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445623-aldeyra-up-60-premarket-on-positive-reproxalap-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra up 60% premarket on positive reproxalap data</a></h4><ul><li>Thinly traded micro cap Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) is up <font color=\"green\">60%</font> premarket on increased volume in reaction to <a href=\"https://seekingalpha.com/pr/17454713-aldeyra-therapeutics-announces-positive-top-line-results-phase-3-alleviate-trial-patients\" target=\"_blank\">positive results</a> from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03494504?lead=aldeyra&amp;phase=2&amp;rank=2\" target=\"_blank\">ALLEVIATE </a>study evaluating reproxalap topical ophthalmic solution in patients with allergic conjunctivitis.</li><li>The study met the primary endpoint and the key secondary endpoint for both strengths assessed.</li><li>Participants receiving either the 0.25% or 0.5% formulations experienced statistically significant reductions in ocular itching compared to vehicle (placebo) (p&lt;0.0001 and p=0.0025, respectively). Two-point responder rates for both doses were also statistically significantly greater than vehicle (p=0.0005 and p=0.0169, respectively).</li><li>The company plans to meet with the FDA in H2 to review the data and clarify a registration path.</li><li>Aldeyra has also closed a $60M loan with Hercules Capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445623\" data-linked=\"Aldeyra up 60% premarket on positive reproxalap data\" data-tweet=\"$ALDX - Aldeyra up 60% premarket on positive reproxalap data https://seekingalpha.com/news/3445623-aldeyra-up-60-premarket-on-positive-reproxalap-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3445623-aldeyra-up-60-premarket-on-positive-reproxalap-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}